Catalyst Pharmaceutical
CPRX
CPRX
379 hedge funds and large institutions have $2.58B invested in Catalyst Pharmaceutical in 2026 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 146 increasing their positions, 119 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 373 → 379 (+6)
0.77% more ownership
Funds ownership: 84.57% → 85.34% (+0.77%)
31% less call options, than puts
Call options by funds: $3.38M | Put options by funds: $4.88M
Holders
379
Holding in Top 10
4
Calls
$3.38M
Puts
$4.88M
Top Buyers
| 1 | +$26.5M | |
| 2 | +$19.9M | |
| 3 | +$16.4M | |
| 4 |
CCMG
Clark Capital Management Group
Philadelphia,
Pennsylvania
|
+$13.5M |
| 5 |
IMC Chicago
Chicago,
Illinois
|
+$13.4M |
Top Sellers
| 1 | -$60M | |
| 2 | -$23.1M | |
| 3 | -$15.8M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$12.9M |
| 5 |
MIM
MetLife Investment Management
Whippany,
New Jersey
|
-$12.6M |
